Latest round: Series B. Bradley Burnam is the CEO of Turn Therapeutics, a biotech company.
Bradley Burnam is the CEO of Turn Therapeutics, a biotech company. He founded the company after developing a cure for himself. Turn Therapeutics has secured an investment commitment tied to a public listing and has obtained three FDA clearances, 16 patents, and achieved over 200,000 patient uses.
Full founder directory · Investor directory · Company funding database · Fundraising library